Schwartz Jeffrey Lawrence
Schwartz Jeffrey Lawrence, DIR, reported an open-market or private sale at KESTRA MEDICAL TECHNOLOGIES, LTD. involving 3890.000000 shares for an estimated $97942.42. Reported holdings after the transaction were 7019.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 08, 2026
- Filing date
- Sep 11, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 10,909 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
KMTS price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0000950130-26-000223 Common Shares
- Transaction date
- Sep 08, 2026 Filed Sep 11, 2026, 12:43 AM · 3d delay
- Shares
- 3,890 sh $25.18 per share
- Estimated value
- -$97.9k Computed from shares × price
- Holdings after
- 7,019 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations…
- F2
The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.9100 to $25.4240. Upon request, the reporting person will provide to the Issuer…
- F3
The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 9, 2027, subject t…
- F4
Represents 25,172,338 common shares of the Issuer held directly by Bain Charger Holdings, L.P. ("Bain Charger"). Mr. Schwartz is a Partner of Bain Capital Investors, LLC, which is the general partner…
0 other transactions
0 recent txs